Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q4 FY26 results · Jan–Mar 2026
Bajaj Healthcare reported revenue from operations of ₹153.06 crore (down 0.9% from Q4 FY25) and net loss of ₹22.85 crore for Q4 FY26 (Jan–Mar 2026), on a standalone basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 153.06 | 154.47 | −0.9% | 161.22 | −5.1% |
| Other income | 2.96 | 13.57 | −78.2% | 1.65 | +79.5% |
| Total income | 156.01 | 168.04 | −7.2% | 162.87 | −4.2% |
| Profit before tax | (20.81) | 11.72 | Turned loss | 19.24 | Turned loss |
| Net profit for the period | (22.85) | 11.18 | Turned loss | 15.67 | Turned loss |
| EPS, basic (₹) | (7.16) | 3.54 | Turned loss | 4.96 | Turned loss |
| Net margin (%) | -14.9 | 7.2 | 9.7 |
Standalone
- Filed with BSE
- 08 May 2026, 22:08 IST
- Board meeting
- 08 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE